We are live on ! Find out more
PVMCV

Polaris Venture Management Co V Portfolio holdings

AUM $14.1M
1-Year Est. Return 121.41%
This Fund
S&P 500
This Quarter Est. Return
-2.72%
1 Year Est. Return
+121.41%
3 Year Est. Return
+281.18%
5 Year Est. Return
+1,023.01%
10 Year Est. Return
–
AUM
$84.2M
AUM Growth
-$10.5M
Cap. Flow
-$1.63M
Cap. Flow %
-1.93%
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
OCUL icon
Ocular Therapeutix
OCUL
+$1.63M

Sector Composition

Rank Sector Weight
1 Healthcare 88.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RNAC icon
1
Cartesian Therapeutics
RNAC
$218M
$33M 39.17%
64,138
– –
TRVN
2
DELISTED
Trevena, Inc.
TRVN
$12.1M 14.33%
3,286
– –
TTOO
3
DELISTED
T2 Biosystems, Inc
TTOO
$9.87M 11.71%
375
– –
GNCA
4
DELISTED
Genocea Biosciences, Inc.
GNCA
$8.11M 9.63%
246,076
– –
OCUL icon
5
Ocular Therapeutix
OCUL
$1.83B
$6.6M 7.84%
788,723
-209,990
-21% -$1.63M
FATE icon
6
Fate Therapeutics
FATE
$275M
$6.21M 7.37%
2,473,186
– –
ATYR
7
aTyr Pharma
ATYR
$47.4M
$3.93M 4.66%
130,571
– –
DARE icon
8
Dare Bioscience
DARE
$17.4M
$2.33M 2.76%
27,396
– –
PULM icon
9
Pulmatrix
PULM
$6.1M
$2.13M 2.53%
18,040
– –

Similar funds

IFC
Intact Financial Corporation Toronto, Ontario, Canada $14M AUM
AG
Ashmore Group London, United Kingdom $16.3M AUM 57.83% 1-Year Est. Return
RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
IR
Invictus RG Hamilton, Bermuda $8.9M AUM 56.32% 1-Year Est. Return
CCM
Copernicus Capital Management San Francisco, California $8.26M AUM 37.91% 1-Year Est. Return
EIP
Edgbaston Investment Partners $20.3M AUM 35.98% 1-Year Est. Return
AAM
Areion Asset Management Hong Kong $7.82M AUM 16% 1-Year Est. Return
OEP
Ocean Endowment Partners Chicago, Illinois $20.6M AUM 27.63% 1-Year Est. Return

Polaris Venture Management Co V's Q4 2016 Portfolio in Review

As of Q4 2016, Polaris Venture Management Co V held 9 positions worth $84.2M, down 11% from $94.7M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2016: portfolio turnover was 0%. Polaris Venture Management Co V opened no new positions and made no exits, leaving the 9-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 88% of assets, up from 86% a quarter earlier.

  • Polaris Venture Management Co V's biggest Q4 2016 reduction was Ocular Therapeutix, cutting an estimated $1.63M.
  • Polaris Venture Management Co V's ten largest holdings make up 100% of its $84.2M portfolio in Q4 2016.
  • Polaris Venture Management Co V opened 0 new positions and closed 0 in Q4 2016.
  • Polaris Venture Management Co V's portfolio value fell 11% quarter-over-quarter to $84.2M.

Based on Polaris Venture Management Co V's 13F filing for Q4 2016, filed 14 Feb 2017.